DANIEL MUSHER to Vancomycin
This is a "connection" page, showing publications DANIEL MUSHER has written about Vancomycin.
Connection Strength
0.625
-
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis. 2009 Feb 15; 48(4):e41-6.
Score: 0.292
-
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin. Scand J Infect Dis. 2012 Aug; 44(8):620-2.
Score: 0.092
-
A 57-year-old man with a fluid-containing lung cavity: infection of an emphysematous bulla with methicillin-resistant Staphylococcus aureus. Chest. 2006 Dec; 130(6):1942-6.
Score: 0.063
-
Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis. 2005 Sep; 5(9):549-57.
Score: 0.058
-
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis. 2005 Jun 01; 40(11):1586-90.
Score: 0.056
-
Clostridium difficile infection in patients with unexplained leukocytosis. Am J Med. 2003 Nov; 115(7):543-6.
Score: 0.051
-
In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. Antimicrob Agents Chemother. 2004 Oct; 48(10):4016-9.
Score: 0.013